Justin Ward
Fortuna: 139 168 $ al 31/05/2026
Fortuna: 139 168 $ al 31/05/2026
Justin Ward is currently the Executive Director & Manager-Quality Assurance at Recce Pharmaceuticals Ltd. He previously worked as a Laboratory Manager at Solbec Pharmaceuticals Ltd. and as a Quality Manager at Phebra Pty Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2025 | 351.684 ( 0,12 % ) | 139 168 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| RECCE PHARMACEUTICALS LTD | Director/Miembro de la Junta | 09/07/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
Phebra Pty Ltd.
Phebra Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies sterile injectable pharmaceutical products | Corporate Officer/Principal | - |
Solbec Pharmaceuticals Ltd.
Solbec Pharmaceuticals Ltd. BiotechnologyHealth Technology Develops and markets therapies for life threatening and debilitating diseases | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Solbec Pharmaceuticals Ltd.
Solbec Pharmaceuticals Ltd. BiotechnologyHealth Technology Develops and markets therapies for life threatening and debilitating diseases | Health Technology |
Phebra Pty Ltd.
Phebra Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies sterile injectable pharmaceutical products | Health Technology |
Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Creates and manufactures antibiotics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.